pre-IPO PHARMA

COMPANY OVERVIEW

Sermonix Pharmaceuticals LLC is a biotechnology company with a targeted focus on bringing female-specific oncology products through proof of concept, clinical development, and regulatory approval.


LOCATION

  • Columbus, OH, USA

  • THERAPEUTIC AREAS

  • Oncology
  • Women's Health

  • WEBSITE

    https://sermonixpharma.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Jun 29, 2023

    Sermonix Pharmaceuticals to Present Two Posters at The Menopause Society 2023 Annual Meeting


    Jun 26, 2023

    Sermonix Pharmaceuticals Announces Article Comparing ‘Traditional’ to ‘Just-in-Time’ Trial Enrollment Models Is Published in JCO Clinical Cancer Informatics


    Jun 5, 2023

    Sermonix Pharmaceuticals Shares ASCO Poster Presentation on Longer Patient Follow-up Results for ELAINE-2 Study in ESR1-mutated Metastatic Breast Cancer


    May 25, 2023

    Sermonix Pharmaceuticals to Share Longer Patient Follow-up Results for ELAINE-2 in Poster Presentation at ASCO 2023


    Mar 15, 2023

    Sermonix Pharmaceuticals Announces E-Poster Presentation on I-SPY 2 Study of Neoadjuvant Lasofoxifene at St. Gallen International Breast Cancer Conference 2023


    For More Press Releases


    Google Analytics Alternative